DRUG COMBINATIONS FOR INHIBITING INFLAMMATION AND SRC KINASE ACTIVATION FOLLOWING INVASIVE SURGICAL PROCEDURES

Combinations of compounds that inhibit activation of p-Src tyrosine kinase, having particularly utility in the treatment of inflammation resulting from traumatic surgical interventions and the proliferation or metastasis of cancer cells following surgical excision of cancerous tissue. La présente in...

Full description

Saved in:
Bibliographic Details
Main Authors VENTURI, MIRO, VOTTA-VELIS, E. GINA, BORGEAT, ALAIN, MITIDIERI, AUGUSTO, DONATI, ELISABETTA
Format Patent
LanguageEnglish
French
Published 10.09.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Combinations of compounds that inhibit activation of p-Src tyrosine kinase, having particularly utility in the treatment of inflammation resulting from traumatic surgical interventions and the proliferation or metastasis of cancer cells following surgical excision of cancerous tissue. La présente invention concerne des associations de composés qui inhibent l'activation de la tyrosine kinase p-Src, ayant une utilité particulière dans le traitement d'une inflammation résultant d'interventions chirurgicales traumatiques et la prolifération ou la métastase de cellules cancéreuses après l'excision chirurgicale de tissu cancéreux.
Bibliography:Application Number: CA20213170998